SYNTHORX, INC.

THOR NASDAQ
15.80
-1.20
-7.06%
盘后: 15.80 0 0.00% 16:51 07/23 EDT
开盘
17.00
昨收
17.00
最高
17.07
最低
15.55
成交量
23.50万
成交均量(3M)
7.69万
52周最高
23.53
52周最低
11.00
换手率
0.86%
市值
4.33亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供SYNTHORX, INC. THOR股票价格,SYNTHORX, INC.股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Synthorx, Inc. is a biopharmaceutical company. The Company is focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders. Its platform technology expands the genetic code by adding a new deoxyribonucleic acid (DNA) base pair and is designed to create optimized biologics, which is referred as Synthorins. The Company’s lead product candidate, THOR-707, is a variant of IL-2 designed to kill tumor cells by increasing CD8+ T and natural killer (NK), cells without causing vascular leak syndrome (VLS), observed with IL-2 (aldesleukin). Its cytokine Synthorin programs, including IL-2, IL-10 and IL-15 for the treatment of cancer, and another IL-2 Synthorin program for the treatment of autoimmune disorders.
展开 >

最近浏览

名称
价格
涨跌幅